05/17/2019

Ogier advises on US$350 million biopharmaceutical merger

The merger transaction was essentially an all share deal, with Xynomic's shareholders receiving shares in Bison equivalent to a closing consideration value of approximately US$ 350 million subject to certain adjustments for debt, cash and working cap

05/15/2019

US SEC Proposes Amendments to Cross-Border Swaps Rules

Among other things, the proposals provide guidance on when transactions are considered to have been “arranged, negotiated, or executed” by US personnel as a trigger for regulating security-based swaps and market participants.